PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
March 20, 2024JAMA Network OpenOpen Access

Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHeidi TaipaleJBJakob BergströmKGKatalin Gémes

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Taipale et al. (2024) studied this question.

synapsesocial.com/papers/68e732b8b6db6435876abb46https://doi.org/10.1001/jamanetworkopen.2024.2859
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study2026
  2. 2ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study2024 · 10 citations
  3. 3ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials.2025 · 44 citations
  4. 4Impact of Medication Therapy on Social, Behavioral, and Employment Outcomes in Adults With ADHD2026
  5. 5Association between attention-deficit/hyperactivity disorder medications and criminal offending in adolescents and adults: a national registry study2024